Advancing natural killer therapies against cancer
- PMID: 35487189
- DOI: 10.1016/j.cell.2022.04.006
Advancing natural killer therapies against cancer
Abstract
Natural killer (NK)-based therapies against cancer are emerging, but the understanding of NK cell functions needs to be completed to optimize these treatments. In this issue, Pan et al. (2022) show that pro-apoptotic molecules, such as BH3-mimetics, synergize with NK cells to induce mitochondria-driven apoptosis in tumor cells, thereby enhancing the efficacy of NK cell therapies.
Copyright © 2022 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests E.V. is an employee of Innate Pharma.
Comment on
-
Augmenting NK cell-based immunotherapy by targeting mitochondrial apoptosis.Cell. 2022 Apr 28;185(9):1521-1538.e18. doi: 10.1016/j.cell.2022.03.030. Epub 2022 Apr 20. Cell. 2022. PMID: 35447071 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
